Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 2925 of 3173 entries
View as:

A Study Of PF-06647020 For Adult Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02222922 Org: User:
Start: 10/17/14 End: 11/05/19 Due: 11/05/20

Study With AG-013736 Combined With Chemotherapy And Bevacizumab In Patients With Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00460603 Org: User:
Start: 01/31/06 End: 11/30/12 Due: 11/30/13

A Study Of PF-04449913 In Japanese Patients With Select Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02038777 Org: User:
Start: 03/25/14 End: 12/28/23 Due: 12/28/24

A Study to Learn About PAXLOVID (a Commercial Medicine) In People With COVID-19

Phase: N/A Priority: Normal
NCT ID: NCT05263908 Org: User:
Start: 03/31/22 End: 07/10/23 Due: 07/10/24

BeneFIX Drug Use Results Survey [All-Case Surveillance]

Phase: N/A Priority: Normal
NCT ID: NCT01154231 Org: User:
Start: 02/28/10 End: 02/27/17 Due: 02/27/18

A Dose-Ranging, Multicenter Polysomnography Trial of PD 0200390 in Elderly Subjects With Primary Insomnia

Phase: N/A Priority: Normal
NCT ID: NCT00748592 Org: User:
Start: 01/31/09 End: 06/30/09 Due: 06/30/10

Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study

Phase: N/A Priority: Normal
NCT ID: NCT03918629 Org: User:
Start: 04/01/19 End: 12/22/20 Due: 12/22/21

A Study to Learn How Different Amounts of the Study Medicine Called PF-07328948 Are Tolerated and Act in the Body in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05807490 Org: User:
Start: 04/05/23 End: 07/10/24 Due: 07/10/25

Korea Post Marketing Surveillance (PMS) Study of Talzenna®

Phase: N/A Priority: Normal
NCT ID: NCT04982848 Org: User:
Start: 12/31/25 End: 10/31/26 Due: 10/31/27

Treatment Patterns and Clinical Outcomes Among Patients With HR+/HER2- mBC Receiving Palbociclib Combination Therapy in the US Community Oncology Setting.

Phase: N/A Priority: Normal
NCT ID: NCT04460911 Org: User:
Start: 10/19/19 End: 04/01/22 Due: 04/01/23

Non-interventional, Retrospective Cohort Study to Explore OAC Treatment in Korea

Phase: N/A Priority: Normal
NCT ID: NCT03572972 Org: User:
Start: 01/31/18 End: 12/20/18 Due: 12/20/19

Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00319254 Org: User:
Start: 05/31/06 End: 02/28/09 Due: 02/28/10

Study to IDEntify Patients With Advanced/Metastatic Non Small Cell Lung Cancer (NSCLC) and ALK and ROS1 Translocation and to Establish Their Therapeutic Management (IDEALK&ROS)

Phase: N/A Priority: Normal
NCT ID: NCT02679170 Org: User:
Start: 06/29/16 End: 05/04/22 Due: 05/04/23

Study of PF-05212384 (Also Known as PKI-587)Administered Intravenously To Subjects With Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00940498 Org: User:
Start: 01/31/10 End: 10/31/12 Due: 10/31/13

PF-06651600 for the Treatment of Alopecia Areata

Phase: N/A Priority: Normal
NCT ID: NCT03732807 Org: User:
Start: 12/03/18 End: 06/24/21 Due: 06/24/22

Study Of The Pharmacokinetics And Safety Of Voriconazole In Children 2 To 11 Years Old Who Are At High Risk For Systemic Fungal Infection

Phase: N/A Priority: Normal
NCT ID: NCT00739934 Org: User:
Start: 12/31/08 End: 10/31/09 Due: 10/31/10

Study Examining The Effect Of Hepatic Impairment On Safety, Toleration And How The Body Processes An Experimental Drug

Phase: N/A Priority: Normal
NCT ID: NCT00645021 Org: User:
Start: 04/30/08 End: 10/31/08 Due: 10/31/09

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events

Phase: N/A Priority: Normal
NCT ID: NCT01968967 Org: User:
Start: 10/29/13 End: 07/10/17 Due: 07/10/18

Ameparomo Capsules 250 mg Drug Use Investigation

Phase: N/A Priority: Normal
NCT ID: NCT02680665 Org: User:
Start: 10/19/15 End: 12/21/18 Due: 12/21/19

Estimation Of Effect Of Rifampin On Pharmacokinetics Of Crizotinib In Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01147055 Org: User:
Start: 07/31/10 End: 10/31/10 Due: 10/31/11

A Study to Learn About the Study Medicine (PF-07293893) at Different Dose Levels in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT05907395 Org: User:
Start: 08/09/23 End: 03/22/24 Due: 03/22/25

Study Evaluating The Efficacy Of Varenicline In Cessation Of Oral Smokeless Tobacco Use

Phase: N/A Priority: Normal
NCT ID: NCT00717093 Org: User:
Start: 08/31/08 End: 07/31/09 Due: 07/31/10

A Multicenter Phase 3, Open-Label Study of Bosutinib Versus Imatinib in Adult Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT02130557 Org: User:
Start: 07/15/14 End: 04/17/20 Due: 04/17/21

Study of RV521 in the Treatment of Adult Subjects Who Have Undergone HCT With an URTI With RSV

Phase: N/A Priority: Normal
NCT ID: NCT04267822 Org: User:
Start: 06/15/20 End: 07/31/23 Due: 07/31/24

Postlicensure Observational Safety Study of 13vPnC Administered to Infants and Toddlers

Phase: N/A Priority: Normal
NCT ID: NCT01128426 Org: User:
Start: 06/30/10 End: 06/30/13 Due: 06/30/14